|
Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts
RECRUITINGN/ASponsored by Tadashi Watabe
Actively Recruiting
PhaseN/A
SponsorTadashi Watabe
Started2022-05-09
Est. completion2026-03-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05442151
Summary
PET / CT examination using \[18F\] FAPI-74 is performed on patients diagnosed with malignant tumor, and the pathological condition is determined by comparing with FDG-PET/CT examination of conventional diagnostic imaging.
Eligibility
Healthy volunteers accepted
Inclusion Criteria: Patients who meet any of the following conditions. 1. Patients who have been diagnosed with malignant tumors or suspected of having malignant tumors and have CT or FDG-PET examination. 2. Patients who have been diagnosed with malignant tumor and are scheduled to receive or have undergone anticancer treatment such as chemotherapy or radiation therapy. 3. Patients suspected of recurrence by clinical findings or diagnostic imaging such as CT or FDG-PET after treatment of malignant tumor Exclusion Criteria: 1. Pregnant women or patients who may be pregnant 2. Pediatric patients requiring sedation 3. Those who are judged to be inappropriate as subjects.
Conditions2
CancerNeoplasms
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorTadashi Watabe
Started2022-05-09
Est. completion2026-03-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05442151